CAS RN: 1123837-84-2

Sitravatinib

Product Availability

Choose a grade to view its available package options.

7 package records7 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250618 100mg In stock Shanghai Inquiry
Batchno.20250815 10mg In stock Shanghai Inquiry
Batchno.20260418 250mg In stock Shanghai Inquiry
Batchno.20260103 25mg In stock Shanghai Inquiry
Batchno.20250524 50mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250601 5mg / 25mg / 100mg Confirm by inquiry Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250923 1ml In stock Inquiry
  • Product code: starshine_CAS1123837-84-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1123837-84-2 / 1-N'-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

Sitravatinib | MGCD516 | MG-516

Standard CAS: 1123837-84-2 Multi CAS: No

Basic Information

CAS
1123837-84-2
Multi CAS
No
Molecular Formula
C33H29F2N5O4S
Molecular Weight
629.700000
Exact Mass
629.190832
SMILES
COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
InChI
InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)
InChIKey
WLAVZAAODLTUSW-UHFFFAOYSA-N
Synonyms
Sitravatinib MGCD516 MG-516 MGCD-516 CWG62Q1VTB

Computed Properties

Structural Parameters

Heavy atom count
45
Aromatic heavy atom count
27
Fraction Csp3
0.21
Rotatable bonds
12
H-bond acceptors
8
H-bond donors
3
Molar refractivity
168.23
TPSA
114.47

LogP / Solubility

WLOGP
6.52
MLOGP
5.79
XLogP3
5.2
Consensus LogP
5.84
Log S (ESOL)
-7.51
Class (ESOL)
Insoluble
Log S (Ali)
-9.43
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.61
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.93

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5.5

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us